Logo image of FLGT

FULGENT GENETICS INC (FLGT) Stock Overview

USA - NASDAQ:FLGT - US3596641098 - Common Stock

22.59 USD
+0.56 (+2.54%)
Last: 9/26/2025, 8:00:00 PM
22.59 USD
0 (0%)
After Hours: 9/26/2025, 8:00:00 PM

FLGT Key Statistics, Chart & Performance

Key Statistics
52 Week High22.87
52 Week Low14.57
Market Cap691.48M
Shares30.61M
Float20.46M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.46
PE49.11
Fwd PEN/A
Earnings (Next)11-06 2025-11-06/bmo
IPO09-28 2016-09-28
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services


FLGT short term performance overview.The bars show the price performance of FLGT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

FLGT long term performance overview.The bars show the price performance of FLGT in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -10 -20 -30 -40

The current stock price of FLGT is 22.59 USD. In the past month the price increased by 2.54%. In the past year, price increased by 6.76%.

FULGENT GENETICS INC / FLGT Daily stock chart

FLGT Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS CVS HEALTH CORP 11.95 96.10B
CI THE CIGNA GROUP 10.19 76.39B
LH LABCORP HOLDINGS INC 18.53 23.32B
DGX QUEST DIAGNOSTICS INC 19.98 21.13B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 126.34 16.56B
FMS FRESENIUS MEDICAL CARE-ADR 12.54 15.01B
HIMS HIMS & HERS HEALTH INC 73 13.20B
DVA DAVITA INC 13.5 9.35B
GH GUARDANT HEALTH INC N/A 7.49B
CHE CHEMED CORP 20.66 6.73B
RDNT RADNET INC 210.86 5.84B
BTSG BRIGHTSPRING HEALTH SERVICES 37.01 4.85B

About FLGT

Company Profile

FLGT logo image Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. The company is headquartered in El Monte, California and currently employs 1,313 full-time employees. The company went IPO on 2016-09-28. Its laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. Its testing services include comprehensive anatomic pathology testing services, including gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology, and precision diagnostics testing services, including next-generation sequencing (NGS), tests for biopharma research and clinical tests for rare disease, hereditary cancer, reproductive health, and many other diseases.

Company Info

FULGENT GENETICS INC

4399 Santa Anita Ave

El Monte CALIFORNIA 91780 US

CEO: Ming Hsieh

Employees: 1313

FLGT Company Website

FLGT Investor Relations

Phone: 16263500537

FULGENT GENETICS INC / FLGT FAQ

What is the stock price of FULGENT GENETICS INC today?

The current stock price of FLGT is 22.59 USD. The price increased by 2.54% in the last trading session.


What is the ticker symbol for FULGENT GENETICS INC stock?

The exchange symbol of FULGENT GENETICS INC is FLGT and it is listed on the Nasdaq exchange.


On which exchange is FLGT stock listed?

FLGT stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for FULGENT GENETICS INC stock?

9 analysts have analysed FLGT and the average price target is 25.84 USD. This implies a price increase of 14.39% is expected in the next year compared to the current price of 22.59. Check the FULGENT GENETICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is FULGENT GENETICS INC worth?

FULGENT GENETICS INC (FLGT) has a market capitalization of 691.48M USD. This makes FLGT a Small Cap stock.


How many employees does FULGENT GENETICS INC have?

FULGENT GENETICS INC (FLGT) currently has 1313 employees.


What are the support and resistance levels for FULGENT GENETICS INC (FLGT) stock?

FULGENT GENETICS INC (FLGT) has a support level at 22.17 and a resistance level at 22.6. Check the full technical report for a detailed analysis of FLGT support and resistance levels.


Is FULGENT GENETICS INC (FLGT) expected to grow?

The Revenue of FULGENT GENETICS INC (FLGT) is expected to grow by 12.97% in the next year. Check the estimates tab for more information on the FLGT EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy FULGENT GENETICS INC (FLGT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does FULGENT GENETICS INC (FLGT) stock pay dividends?

FLGT does not pay a dividend.


When does FULGENT GENETICS INC (FLGT) report earnings?

FULGENT GENETICS INC (FLGT) will report earnings on 2025-11-06, before the market open.


What is the Price/Earnings (PE) ratio of FULGENT GENETICS INC (FLGT)?

The PE ratio for FULGENT GENETICS INC (FLGT) is 49.11. This is based on the reported non-GAAP earnings per share of 0.46 and the current share price of 22.59 USD. Check the full fundamental report for a full analysis of the valuation metrics for FLGT.


What is the Short Interest ratio of FULGENT GENETICS INC (FLGT) stock?

The outstanding short interest for FULGENT GENETICS INC (FLGT) is 10.03% of its float. Check the ownership tab for more information on the FLGT short interest.


FLGT Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to FLGT. When comparing the yearly performance of all stocks, FLGT turns out to be only a medium performer in the overall market: it outperformed 68.86% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

FLGT Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to FLGT. While FLGT seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FLGT Financial Highlights

Over the last trailing twelve months FLGT reported a non-GAAP Earnings per Share(EPS) of 0.46. The EPS increased by 1433.33% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -4.25%
ROE -4.57%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-53.33%
Sales Q2Q%15.17%
EPS 1Y (TTM)1433.33%
Revenue 1Y (TTM)4.3%

FLGT Forecast & Estimates

9 analysts have analysed FLGT and the average price target is 25.84 USD. This implies a price increase of 14.39% is expected in the next year compared to the current price of 22.59.

For the next year, analysts expect an EPS growth of -192.98% and a revenue growth 12.97% for FLGT


Analysts
Analysts80
Price Target25.84 (14.39%)
EPS Next Y-192.98%
Revenue Next Year12.97%

FLGT Ownership

Ownership
Inst Owners53.98%
Ins Owners33.16%
Short Float %10.03%
Short Ratio7.48